IQVIA 2025 Shareholder Meeting Summary

At its 2025 Annual Meeting, IQVIA shareholders approved a charter amendment granting officer liability protection under Delaware law and elected all nine director nominees. Executive compensation for 2024 and the appointment of PwC as auditor were also approved. A shareholder proposal for special stockholder meetings was rejected.

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025.

The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. Announces Amendment to Credit Agreement to Lower Interest Rate and Repay Euro Loans
Durham, NC – March 10, 2025 – IQVIA Holdings Inc. (NYSE: IQV) has announced that it has entered into an amendment to its Fifth Amended and Restated Credit Agreement to refinance and modify certain loan terms.

Key Updates in the Amendment:
Refinancing of Term B-4 Dollar Loans:
The interest rate on borrowings will be reduced from SOFR + 2.00% to SOFR + 1.75% per annum.
Full Repayment of Term B-2 Euro Loans:
The company will fully repay its Term B-2 Euro Loans, streamlining its debt obligations.
This amendment is expected to improve the company’s financial flexibility and reduce borrowing costs.

A copy of the full amendment has been filed as Exhibit 10.1 to IQVIA’s Form 8-K and is incorporated by reference.

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

*February 6, 2025* — IQVIA (NYSE: IQV) announced its financial results for the fourth quarter and full year of 2024, along with reaffirmed guidance for 2025.

- Fourth-Quarter Results:
- Revenue reached $3,958 million.
- GAAP Net Income was $437 million, or $2.42 per diluted share.
- Adjusted EBITDA totaled $996 million, with Adjusted Diluted Earnings per Share at $3.12.
- Operating Cash Flow was $885 million, contributing to full-year Operating Cash Flow of $2,716 million, up 26% year-over-year.
- Free Cash Flow for the quarter was $721 million, bringing full-year Free Cash Flow to $2,114 million, up 41% year-over-year.

- Full-Year Results:
- Revenue totaled $15,405 million.
- GAAP Net Income was $1,373 million, or $7.49 per diluted share.
- Adjusted EBITDA was $3,684 million, with Adjusted Diluted Earnings per Share at $11.13.
- The company reported R&D Solutions bookings exceeding $2.5 billion, resulting in a book-to-bill ratio of 1.20x. R&D Solutions' contracted backlog was $31.1 billion, up 5.5% year-over-year at constant currency.
- TAS Revenue for Q4 was $1,658 million, up 9.5% from Q4 2023, and $6,160 million for the full year, up 5.7% year-over-year, both at constant currency.

- 2025 Guidance:
- IQVIA reaffirmed its 2025 outlook with revenue growth at constant currency, excluding COVID-related impact, expected between 4% to 7%.
- Adjusted EBITDA margin is expected to expand by up to 20 basis points, and Adjusted Diluted Earnings per Share is forecasted to grow by 5% to 9%.
- Full-year 2025 Revenue guidance is $15,725 million to $16,125 million, with Adjusted EBITDA ranging from $3,765 million to $3,885 million and Adjusted Diluted Earnings per Share projected at $11.70 to $12.10.